We are live on ! Find out more
Bank of New York Mellon

Bank of New York Mellon Portfolio holdings

AUM $609B
1-Year Est. Return 40.19%
 

Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.

This Fund
S&P 500
This Quarter Est. Return
+8.51%
1 Year Est. Return
+40.19%
3 Year Est. Return
+118.86%
5 Year Est. Return
+156%
10 Year Est. Return
+606.23%
AUM
$517B
AUM Growth
+$27.6B
Cap. Flow
-$8.37B
Cap. Flow %
-1.62%
Top 10 Hldgs %
19.4%
Holding
4,590
New
277
Increased
1,772
Reduced
2,129
Closed
201

Top Sells

Rank Stock Value
1
FERG icon
Ferguson
FERG
+$692M
2
LIN icon
Linde
LIN
+$624M
3
MDT icon
Medtronic
MDT
+$527M
4
GS icon
Goldman Sachs
GS
+$340M
5
MSFT icon
Microsoft
MSFT
+$301M

Sector Composition

Rank Sector Weight
1 Technology 25.11%
2 Healthcare 13.18%
3 Financials 12.45%
4 Consumer Discretionary 10.8%
5 Communication Services 8.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEXI
3851
DELISTED
NexImmune, Inc. Common Stock
NEXI
$298K ﹤0.01%
730
+173
+31% +$79.7K
EFAV icon
3852
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.46B
$297K ﹤0.01%
+3,932
New +$296K
IIN
3853
DELISTED
IntriCon Corporation
IIN
$297K ﹤0.01%
13,207
-14,270
-52% -$331K
FRHC icon
3854
Freedom Holding
FRHC
$9.35B
$291K ﹤0.01%
4,469
-614
-12% -$32.5K
FXL icon
3855
First Trust Technology AlphaDEX Fund
FXL
$2.89B
$291K ﹤0.01%
+2,343
New +$278K
RMBI icon
3856
Richmond Mutual Bancorp
RMBI
$256M
$291K ﹤0.01%
19,538
-32,261
-62% -$455K
SGTX
3857
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$290K ﹤0.01%
2,081
+752
+57% +$132K
FRAF icon
3858
Franklin Financial Services
FRAF
$289M
$289K ﹤0.01%
9,043
-11,132
-55% -$338K
RWX icon
3859
State Street SPDR Dow Jones International Real Estate ETF
RWX
$267M
$286K ﹤0.01%
+7,800
New +$286K
SACH
3860
Sachem Capital Corp
SACH
$37.6M
$286K ﹤0.01%
53,497
+41,580
+349% +$217K
TERN
3861
DELISTED
Terns Pharmaceuticals
TERN
$286K ﹤0.01%
23,286
+4,007
+21% +$68.3K
SPRB
3862
Spruce Biosciences
SPRB
$143M
$286K ﹤0.01%
341
+85
+33% +$90.7K
NEXT icon
3863
NextDecade
NEXT
$1.8B
$283K ﹤0.01%
68,517
-45,317
-40% -$128K
MFIN icon
3864
Medallion Financial
MFIN
$262M
$279K ﹤0.01%
31,444
-1
-0% -$9
SMMT icon
3865
Summit Therapeutics
SMMT
$11.2B
$277K ﹤0.01%
+37,114
New +$243K
LVTX
3866
DELISTED
LAVA Therapeutics
LVTX
$275K ﹤0.01%
25,288
-9,031
-26% -$112K
IQDF icon
3867
FlexShares International Quality Dividend Index Fund
IQDF
$1.18B
$274K ﹤0.01%
+10,315
New +$276K
NPCE icon
3868
Neuropace
NPCE
$498M
$274K ﹤0.01%
+11,499
New +$267K
APTX
3869
DELISTED
Aptinyx Inc. Common Stock
APTX
$274K ﹤0.01%
96,630
-88,213
-48% -$246K
CBAN icon
3870
Colony Bankcorp
CBAN
$471M
$272K ﹤0.01%
15,201
-22,228
-59% -$373K
AP icon
3871
Ampco-Pittsburgh
AP
$190M
$271K ﹤0.01%
44,587
-1,273
-3% -$8.63K
PSO icon
3872
Pearson
PSO
$9.78B
$269K ﹤0.01%
23,186
+1,119
+5% +$13.1K
GXC icon
3873
State Street SPDR S&P China ETF
GXC
$469M
$268K ﹤0.01%
2,021
SYBX
3874
DELISTED
Synlogic
SYBX
$267K ﹤0.01%
4,572
-723
-14% -$39.5K
GEOS icon
3875
Geospace Technologies
GEOS
$66.5M
$266K ﹤0.01%
32,939
-395
-1% -$3.25K

Similar funds

Bank of New York Mellon's Q2 2021 Portfolio in Review

As of Q2 2021, Bank of New York Mellon held 4,590 positions worth $517B, up 5.6% from $489B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Bank of New York Mellon's Q2 2021 filing shows 277 new, 1,772 increased, 2,129 reduced and 201 closed positions. Its largest new stake was Organon & Co: 4,240,135 shares worth $128M. The largest sale was Ferguson, an estimated $692M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

  • Bank of New York Mellon's largest Q2 2021 buy was Organon & Co: 4,240,135 shares worth $128M.
  • Bank of New York Mellon added most to Vanguard FTSE Developed Markets ETF in Q2 2021, an estimated $307M increase.
  • Bank of New York Mellon's biggest Q2 2021 reduction was Ferguson, cutting an estimated $692M.
  • Bank of New York Mellon fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $164M.
  • Bank of New York Mellon's ten largest holdings make up 19% of its $517B portfolio in Q2 2021.
  • Bank of New York Mellon opened 277 new positions and closed 201 in Q2 2021.
  • Bank of New York Mellon's portfolio value rose 5.6% quarter-over-quarter to $517B.

Based on Bank of New York Mellon's 13F filing for Q2 2021, filed 11 Aug 2021.